INSIDERFilingvia Quantisnow
OpGen Inc. logo

OpGen (OPGN) director Ben-Tzvi received 100,000 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Avraham Ben-Tzvi (director at OpGen Inc., OPGN) reported that they received 100,000 shares on Apr 11, 2024. After these transactions the filing shows 100,000 shares held directly.

Reporting person
Ben-Tzvi Avraham
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Apr 11, 2024Grant or award (A)Common Stock1+100,000--100,000 direct

Holdings before and after

  • Common Stock: 0 to 100,000 direct

Footnotes from the filing

  1. 1. Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Ben-Tzvi report in this OPGN Form 4?

Avraham Ben-Tzvi (director at OpGen Inc., OPGN) reported that they received 100,000 shares on Apr 11, 2024. After these transactions the filing shows 100,000 shares held directly.

How many OPGN shares does Ben-Tzvi hold after this filing?

The filing shows 100,000 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for OPGN

Earlier insider filings at OPGN

Quantisnow market dataNASDAQ
OpGen Inc. logo
OPGN
OpGen Inc.
Market cap
30-day
Sector
Health Care
Industry
Medical Specialities
Listed since
2015
Get push alerts for OPGN

Follow OPGN and get a push notification the moment its next story breaks.

Full OPGN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPGN (OpGen Inc.) and more on Quantisnow.